Tsouristakis AI, Febres G, McMahon DJ, Tchang B, Conwell IM, Tsang AJ, et al
Conclusion GLP-1 agonists have ushered in a new era for obesity treatment, providing substantial benefits for weight loss and metabolic health
Animal venoms have proven to be among natures most sophisticated pharmacological librariesmolecular arsenals honed by evolution for predation and defense that often target precisely the same receptors and channels that interest drug developers
In trials, exenatide improved post-meal glucose spikes (due to its gastric slowing effect and insulin boost after meals) and also moderately lowered fasting glucose
If gastrointestinal symptoms are intolerable, your doctor can adjust the treatment plan appropriately, which may include temporarily reducing the dose or considering alternative weight management strategies